| 000 | 01033 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250512232740.0 | ||
| 264 | 0 | _c19810709 | |
| 008 | 198107s 0 0 eng d | ||
| 022 | _a0009-3157 | ||
| 024 | 7 |
_a10.1159/000237976 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGrüneberg, R N | |
| 245 | 0 | 0 |
_aPrevention of emergence of bacterial resistance: no advantage in combining rifampicin and tetracycline over use of tetracycline alone. _h[electronic resource] |
| 260 |
_bChemotherapy _c1981 |
||
| 300 |
_a188-91 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aDrug Resistance, Microbial |
| 650 | 0 | 4 |
_aEnterococcus faecalis _xdrug effects |
| 650 | 0 | 4 |
_aRifampin _xpharmacology |
| 650 | 0 | 4 |
_aTetracycline _xpharmacology |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aEmmerson, A M | |
| 773 | 0 |
_tChemotherapy _gvol. 27 _gno. 3 _gp. 188-91 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000237976 _zAvailable from publisher's website |
| 999 |
_c6784771 _d6784771 |
||